Theresa MacDonald is Director of Strategy at the Englander Institute. In this role, she is responsible for developing strategic plans and new initiatives for the institute. Current plans include expanding patient access to precision medicine to new clinics and WCM sites and forming industry partnerships focused on genomics-driven drug discovery and clinical utility assessment of genomic medicine.

Ms. MacDonald has 15 years’ experience in academic centers including Weill Cornell Medicine and Beth Israel Deaconess.  She graduated from McGill University with a BA in English Literature and obtained her MBA from Johns Hopkins University Carey School of Business.